Discover
CABA
Cabaletta Bio, Inc.
2.99
2 x 2.24
2 x 3.76
bid
ask
-
0.12
3.86%
2 @ 06:06 AM
3.03 +0.04 (1.34%)
| Ytd | 36.53% | |
| 1y | 91.67% |
2.92
day range
3.18
1.26
52 week range
4.23
| Open | 3.11 | Prev Close | 3.11 | Low | 2.92 | High | 3.18 | Mkt Cap | 487.53M |
| Vol | 5.68M | Avg Vol | 4.35M | EPS | -1.78 | P/E | N/A | Forward P/E | -0.98 |
| Beta | 2.42 | Short Ratio | 4.26 | Inst. Own | 100.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.31 | 200-d Avg | 2.81 | 1yr Est | 22.22 |
CABA News
seekingalpha.com
Cabaletta Bio: The Market Sold The EULAR News, I'm Buying
Cabaletta Bio (CABA) offers a de-risked, breadth-first CAR-T platform for autoimmune diseases, with
benzinga.com
Cabaletta Bio Presents New Clinical Data Supporting Rese-Cel As Potential Treatment For Multiple Aut
83% of dermatomyositis patients in the Phase 1/2 RESET-Myositis study would have met the registratio